Once daily long‐acting beta 2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

International Journal of Nursing Practice ◽

10.1111/ijn.12982 ◽

2021 ◽

Author(s):

Abdullahi S. Ibrahim

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Once Daily ◽

Beta 2 ◽

Long Acting

Download Full-text

Once daily Long-acting beta2 -agonists/Inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012355 ◽

2016 ◽

Cited By ~ 1

Author(s):

Agnieszka Sliwka ◽

Milosz Jankowski ◽

Iwona Gross-Sondej ◽

Roman Nowobilski ◽

Malgorzata M Bala

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Once Daily ◽

Long Acting

Download Full-text

Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012930 ◽

2018 ◽

Cited By ~ 1

Author(s):

Usman Maqsood ◽

David JW Evans ◽

Terence N Ho ◽

Karen Palmer ◽

Fiona JR Eccles ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Once Daily ◽

Long Acting

Download Full-text

Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012355.pub2 ◽

2018 ◽

Cited By ~ 1

Author(s):

Agnieszka Sliwka ◽

Milosz Jankowski ◽

Iwona Gross-Sondej ◽

Monika Storman ◽

Roman Nowobilski ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Once Daily ◽

Beta Agonists ◽

Long Acting

Download Full-text

Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012930.pub2 ◽

2019 ◽

Cited By ~ 1

Author(s):

Usman Maqsood ◽

Terence N Ho ◽

Karen Palmer ◽

Fiona JR Eccles ◽

Mohammed Munavvar ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Once Daily ◽

Long Acting

Download Full-text

Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease

Future Medicinal Chemistry ◽

10.4155/fmc.11.127 ◽

2011 ◽

Vol 3 (13) ◽

pp. 1623-1634 ◽

Cited By ~ 9

Author(s):

Jakob Busch-Petersen ◽

Dramane I Lainé

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Long Acting

Download Full-text

Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd006101 ◽

2006 ◽

Cited By ~ 10

Author(s):

Sarah Appleton ◽

Terry Jones ◽

Phillippa Poole ◽

Toby J Lasserson ◽

Robert Adams ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Ipratropium Bromide ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Beta 2 ◽

Long Acting

Download Full-text

Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease

Respiratory Medicine ◽

10.1016/j.rmed.2019.05.010 ◽

2019 ◽

Vol 153 ◽

pp. 38-43 ◽

Cited By ~ 14

Author(s):

James F. Donohue ◽

Edward Kerwin ◽

Sanjay Sethi ◽

Brett Haumann ◽

Srikanth Pendyala ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Phase 3 ◽

Obstructive Pulmonary Disease ◽

Once Daily ◽

Muscarinic Antagonist ◽

Long Acting

Download Full-text

COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Respirology ◽

10.1111/resp.13420_435 ◽

2018 ◽

Vol 23 ◽

pp. 247-247

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Beta Agonists ◽

Long Acting

Download Full-text

Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s35990 ◽

2012 ◽

pp. 673 ◽

Cited By ~ 18

Author(s):

Charlotte Ulrik

Keyword(s):

Systematic Review ◽

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Clinical Benefit ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Once Daily ◽

Muscarinic Antagonist ◽

Glycopyrronium Bromide ◽

Long Acting

Download Full-text

Compare the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease

Tuberkuloz ve Toraks ◽

10.5578/tt.10778 ◽

2016 ◽

Vol 64 (2) ◽

pp. 112-118 ◽

Cited By ~ 2

Author(s):

Pınar SARAÇ ◽

Abdullah SAYINER

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Obstructive Pulmonary Disease ◽

Inhaled Steroids ◽

Beta 2 ◽

Long Acting

Download Full-text